Your browser doesn't support javascript.
loading
Ensemble Docking Approach to Mitigate Pregnane X Receptor-Mediated CYP3A4 Induction Risk.
Chen, Qi; Zhou, Xin; Rehmel, Jessica; Steele, James P; Svensson, Kjell A; Beck, James P; Hembre, Erik J; Hao, Junliang.
Affiliation
  • Chen Q; Discovery Chemistry Research and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana46285, United States.
  • Zhou X; Drug Disposition, Lilly Biotechnology Center, Eli Lilly and Company, 10290 Campus Point Drive, San Diego, California92121, United States.
  • Rehmel J; Drug Disposition, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana46285, United States.
  • Steele JP; Quantitative Biology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana46285, United States.
  • Svensson KA; Neuroscience Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana46285, United States.
  • Beck JP; Discovery Chemistry Research and Technologies, Lilly Biotechnology Center, Eli Lilly and Company, 10290 Campus Point Drive, San Diego, California92121, United States.
  • Hembre EJ; Discovery Chemistry Research and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana46285, United States.
  • Hao J; Discovery Chemistry Research and Technologies, Lilly Biotechnology Center, Eli Lilly and Company, 10290 Campus Point Drive, San Diego, California92121, United States.
J Chem Inf Model ; 63(1): 173-186, 2023 01 09.
Article in En | MEDLINE | ID: mdl-36473234

Full text: 1 Database: MEDLINE Main subject: Receptors, Steroid / Cytochrome P-450 CYP3A Type of study: Etiology_studies / Risk_factors_studies Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Receptors, Steroid / Cytochrome P-450 CYP3A Type of study: Etiology_studies / Risk_factors_studies Language: En Year: 2023 Type: Article